Companies / BOC Sciences / Zolimomab aritox
BOC Sciences

Zolimomab aritox | BOC Sciences

Zolimomab aritox is a mouse monoclonal antibody directed against CD5, which is developed for the treatment of systemic lupus erythematosus and graft-versus-host disease.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.